Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScancell Holdings Share News (SCLP)

Share Price Information for Scancell Holdings (SCLP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 10.10
Bid: 9.70
Ask: 10.50
Change: 0.00 (0.00%)
Spread: 0.80 (8.247%)
Open: 10.10
High: 10.10
Low: 10.10
Prev. Close: 10.10
SCLP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Oxford Technology Venture Capital Funds Suffer Value Drop

Wed, 19th Oct 2016 11:05

LONDON (Alliance News) - Oxford Technology Management reported Wednesday a reduction in net asset value across all four of its London-listed venture capital funds in the first half of their financial years.

Oxford Technology VCT PLC reported its NAV per share reduced to 59.7 pence from 61.2p in the six months to August 31, as the fund's net assets dropped to GBP3.2 million at the end of the period, down from GBP3.3 million at February 29.

The fund reported a total NAV return per share of 113.7p in the six month period. The share price of the fund slipped to 38.0p at August 31 from 40.5p at February 29.

Shares in Oxford Technology VCT were untraded at 42.87p Wednesday.

Chairman Alex Starling noted over 85% of Oxford Technology VCT's net asset value is bound up in holdings in private company Select Technology Ltd and AIM-listed biotechnology company Scancell Holdings PLC. Starling said recent changes to qualification conditions for being a venture capital trust will not be an issue for the fund as it is not looking to invest in any new companies.

Oxford Technology 2 VCT PLC reported its NAV per share dipped to 28.0p from 28.2p over the six months to August 31, with net assets broadly flat at GBP1.9 million.

Total NAV return per share in the fund was 41.0p. The share price of Oxford Technology 2 rose to 22.0p at August 31 from 20.0p at February 29.

Shares in Oxford Technology VCT 2 were untraded at 18.43p Wednesday.

Oxford Technology VCT 3 PLC's NAV per share fell to 87.3p from 101.6p over the six months to August 31, as net assets declined to GBP5.9 million from GBP6.9 million.

The fund produced a total NAV return per share for the period of 119.3p. The share price of Oxford Technology 3 fell to 57.5p at August 31 from 62.5p at February 29.

Shares in Oxford Technology VCT 3 were untraded at 50.00p Wednesday.

Oxford Technology VCT 4 PLC reported its NAV per share declined slightly to 66.5p from 66.8p over the six months to August 31, with net assets broadly flat at GBP7.7 million. The fund's total NAV return per share for the period was 103.5p. The share price of Oxford Technology 4 fell to 47.0p at August 31 from 52.0p at February 29.

Shares in Oxford Technology VCT 4 were untraded at 45.0p Wednesday.

Oxford Technology VCT 4 Chairman David Livesley noted minor rises in the value of some of the fund's portfolio companies had been more than offset by a fall in the share price of Castleton Technology PLC over the period.

By Adam Clark; adamclark@alliancenews.com

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
11 Apr 2022 13:10

Scancell opens recruitment for cancer therapy trial

(Sharecast News) - Immunotherapy developer Scancell announced on Monday that its phase 1 and 2 clinical trial with 'Modi-1' is open for recruitment.

Read more
11 Apr 2022 12:02

LONDON MARKET MIDDAY: CAC moves green for Macron, FTSE 100 lags

(Alliance News) - Stocks in Europe were having a mixed day on Monday, with the FTSE 100 feeling the weight of a poor UK GDP reading, but the CAC 40 in Paris gaining as investors in France show confidence in President Emmanuel Macron - as he looks set to extend his time in office.

Read more
11 Apr 2022 11:17

Scancell shares soar as clinical trial opens for recruitment

(Alliance News) - Scancell Holdings PLC shares soared on Monday after the cancer immunotherapies developer said its phase 1/2 clinical trial with Modi-1 has opened for recruitment.

Read more
29 Mar 2022 19:21

IN BRIEF: Scancell broadens Covidity clinical trial in South Africa

Scancell Holdings PLC - Nottingham, England-based cancer immunotherapies developer - Updates on South African Health Products Regulatory Authority's approval of a protocol amendment to the phase 1 Covidity clinical trial being conducted at the University of Cape Town Lung Institute in South Africa.

Read more
17 Mar 2022 21:02

TRADING UPDATES: SimiGon merger to go ahead; Segro launches green bond

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
22 Feb 2022 11:50

Image Scan sinks as it expects to post significant loss in first half

(Alliance News) - Image Scan Holdings PLC shares tanked on Tuesday after the company said it expects to post a significant loss for the first half of financial 2022 and thinks it is "unlikely" that the second half will fully recover the loss.

Read more
31 Jan 2022 22:07

TRADING UPDATES: MJ Hudson and Tandem see results ahead of views

TRADING UPDATES: MJ Hudson and Tandem see results ahead of views

Read more
26 Jan 2022 20:18

TRADING UPDATES: Somero upbeat after strong year; Scancell in profit

TRADING UPDATES: Somero upbeat after strong year; Scancell in profit

Read more
19 Jan 2022 16:02

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
19 Nov 2021 13:49

Scancell treats first patient in melanoma tumour trial

(Sharecast News) - Cancer and infectious disease immunotherapy developer Scancell announced on Friday that the enrolment and treatment of the first patient had taken place in its multicentre phase 2 clinical trial of its 'SCIB1' tumour treatment at the Churchill Hospital in Oxford.

Read more
19 Nov 2021 11:37

IN BRIEF: Scancell starts SCIB1 phase 2 trial in UK after pause

IN BRIEF: Scancell starts SCIB1 phase 2 trial in UK after pause

Read more
16 Nov 2021 16:09

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
2 Nov 2021 15:20

DIRECTOR DEALINGS: MD of Gleeson Homes buys GBP150,000 in shares

DIRECTOR DEALINGS: MD of Gleeson Homes buys GBP150,000 in shares

Read more
1 Nov 2021 06:57

IN BRIEF: Kings Arms Yard VCT appoints two new non-executive directors

IN BRIEF: Kings Arms Yard VCT appoints two new non-executive directors

Read more
29 Oct 2021 20:28

TRADING UPDATES: Asia Dragon beats benchmark, Henderson Far East lags

TRADING UPDATES: Asia Dragon beats benchmark, Henderson Far East lags

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.